EZU-33440-19034
3 vaccinations
8 coded responses
34 check-ins
8 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 12-15
- ZIP prefix
- 953 / CA
- Registered
- 2021-11-23
- Relationship
- Child or adolescent in my care
- Guardian
- C7A-35460-44753
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-11-23
Registered in v-safe
-
2022-01-11
Dose 1 — Pfizer-BioNTech
-
2022-01-13
Survey response — days 1–6 daily, dose 1, dependentMedDRA: Joint range of motion decreased, Pain in extremity — Feeling: Good · Site: PainFree text: His arm was sore with limited range of movement on 11/12/22; this was his only symptomMedDRA releases: 2024-11 · check-in free text available
- 2022-01-15
- 2022-01-16
-
2022-01-18
Survey response — day 7, dose 1, dependentMedDRA: Lymphadenopathy, Tenderness — Feeling: GoodFree text: Right supraclavicular lymphadenopathy with mod tenderness discovered today.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-25
-
2022-02-01
Dose 2 — Pfizer-BioNTech
- 2022-02-01
-
2022-02-03
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Fatigue or tiredness · Be unable to work or attend schoolFree text: Cervical lymphadenopathy 2 nodes with tendernessMedDRA releases: 2024-11 · check-in free text available
-
2022-02-04
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Lymphadenopathy — Feeling: GoodFree text: Left supraclavicular lymphadenopathy with 2 nodes affectedMedDRA releases: 2024-11 · check-in free text available
-
2022-02-05
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Left supraclavicular lymphadenopathy 2 nodes with tendernessMedDRA releases: 2024-11 · check-in free text available
-
2022-02-06
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Lymph node pain, Lymphadenopathy — Feeling: GoodFree text: Left supraclavicular lymphadenopathy with mild tendernessMedDRA releases: 2024-11 · check-in free text available
-
2022-02-07
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Lymphadenopathy — Feeling: GoodFree text: Left supraclavicular lymphadenopathy without tenderness 2 nodesMedDRA releases: 2024-11 · check-in free text available
-
2022-02-08
Survey response — day 7, dose 2, dependentMedDRA: Lymphadenopathy — Feeling: GoodFree text: Left supraclavicular lymphadenopathy without tenderness 2 nodesMedDRA releases: 2024-11 · check-in free text available
- 2022-02-15
- 2022-02-22
- 2022-03-01
- 2022-03-08
- 2022-03-15
- 2022-05-03
- 2022-08-02
-
2022-11-12
Dose 3 — Pfizer-BioNTech
- 2022-11-12
-
2022-11-13
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Good · Site: Pain · NoneAdult check-in
- 2022-11-14
- 2022-11-15
- 2022-11-16
- 2022-11-17
- 2022-11-18
- 2022-11-19
- 2022-11-26
- 2022-12-03
- 2022-12-10
- 2022-12-18
- 2022-12-24
- 2023-02-12
- 2023-05-13
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-01-11 | Pfizer-BioNTech | No |
| 2 | 2022-02-01 | Pfizer-BioNTech | No |
| 3 | 2022-11-12 | Pfizer-BioNTech | No |
Free text
Release 10 — days 1–6 daily, dose 1, dependent
Systemic reaction (other): His arm was sore with limited range of movement on 11/12/22; this was his only symptom
Release 10 — day 7, dose 1, dependent
Systemic reaction (other): Right supraclavicular lymphadenopathy with mod tenderness discovered today.
Release 11 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Cervical lymphadenopathy 2 nodes with tenderness
Systemic reaction (other): Left supraclavicular lymphadenopathy with 2 nodes affected
Systemic reaction (other): Left supraclavicular lymphadenopathy 2 nodes with tenderness
Systemic reaction (other): Left supraclavicular lymphadenopathy with mild tenderness
Systemic reaction (other): Left supraclavicular lymphadenopathy without tenderness 2 nodes
Release 11 — day 7, dose 2, dependent
Systemic reaction (other): Left supraclavicular lymphadenopathy without tenderness 2 nodes
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Joint range of motion decreased | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
| SRO | Pain in extremity | · | · | ✓ |
| SRO | Tenderness | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release